LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article: Possible Role of

    Aref, Zaki F / Bazeed, Shamardan Ezzeldin Sayed / Nafady, Asmaa / Fahim, Dalia Fahim Mohammed / Ghweil, Ali A / Sayed, Mennatallah Ali Abdelrhman / Qubaisy, Heba Mohammad / Khalefa, Mahmoud / Arafa, Usama A / Badawy, Badawy Shahat / Abdelmohsen, Ahmed Shawkat / Hassan, Mohammed H / Abdelmaksoud, Aida A

    Infection and drug resistance

    2023  Volume 16, Page(s) 3497–3509

    Abstract: Background: Helicobacter pylori: Patients and methods: A total of 186 patients with various ear, nose and throat diseases were included. The study comprised 78 children with chronic adenotonsillitis, 43 children with nasal polyps and 65 children with ...

    Abstract Background: Helicobacter pylori
    Patients and methods: A total of 186 patients with various ear, nose and throat diseases were included. The study comprised 78 children with chronic adenotonsillitis, 43 children with nasal polyps and 65 children with OME. OME patients were assigned to two subgroups: those who have and those who did not have adenoid hyperplasia. Among the patients with bilateral nasal polyps, 20 individuals had recurrent nasal polyps and 23 had de novo nasal polyps. Patients who have chronic adenotonsillitis were divided into three groups: those with chronic tonsillitis and those who underwent tonsillitis, those with chronic adenoiditis and adenoidectomy was performed, and those with chronic adenotonsillitis and underwent adenotonsillectomy. In addition to examination of
    Results: Frequency of
    Conclusion: Lack of association between
    Language English
    Publishing date 2023-06-02
    Publishing country New Zealand
    Document type Journal Article
    ZDB-ID 2494856-1
    ISSN 1178-6973
    ISSN 1178-6973
    DOI 10.2147/IDR.S411867
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Lactoferrin versus Long-Acting Penicillin in Reducing Elevated Anti-Streptolysin O Titer in Cases of Tonsillopharyngitis.

    Ahmed Abdelmaksoud, Aida / Nafady, Asmaa / Ezzeldin Sayed Bazeed, Shamardan / Khalefa, Mahmoud / Elsamman, Mahmoud K / Abdelrhman Sayed, Mennatallah Ali / Qubaisy, Heba Mohammad / Ghweil, Ali A / Aref, Zaki F

    Infection and drug resistance

    2022  Volume 15, Page(s) 5257–5263

    Abstract: Background: Beta-Hemolytic streptococci are the most frequent bacteria causing tonsillitis. Lactoferrin may play a role in the treatment of chronic tonsillitis due to its direct antimicrobial activity.: Objective: To assess the possible role of ... ...

    Abstract Background: Beta-Hemolytic streptococci are the most frequent bacteria causing tonsillitis. Lactoferrin may play a role in the treatment of chronic tonsillitis due to its direct antimicrobial activity.
    Objective: To assess the possible role of lactoferrin in reduction of raised serum Anti-Streptolysin O Titer (ASOT) in cases of chronic tonsillopharyngitis in comparison to long acting penicillin.
    Methods: This study included 117 children with tonsillopharyngitis with high ASOT randomly divided into three groups; group 1 treated with lactoferrin, group 2 treated with long acting penicillin and group 3 treated with both drugs. For all patients ASOT was measured after three and six months of starting treatment.
    Results: This study included 60 males and 57 females with the mean age (8.5 ± 2.4). There is statistically significant reduction in ASOT in all groups after three months of treatment. ASOT after 3 months was significantly lower in group1 (370±440) and group 3 (350±450) in comparison to group 2 (420±560) with p value 0.02, 0.004, respectively, with no significant difference in comparing group 1 to group 3 p value 0.4. Also, ASO titre after 6 months was significantly lower in group1 (350±420) and group 3 (340±440) in comparison to group 2 (420±550) with p value 0.02, 0.007, respectively, with no significant difference in comparing group 1 to group 3 p value 0.5. In comparing ASOT at three months and six months of treatment in the three studied groups; it decreased by 2% in group 1, and 1.6% in group 3 and no change in group 2.
    Conclusion: Lactoferrin alone or in combination with long acting penicillin is safe and more effective than long acting penicillin alone in reducing ASOT. Treatment for six months with lactoferrin alone or in combination with long acting penicillin could offer a better response.
    Language English
    Publishing date 2022-09-06
    Publishing country New Zealand
    Document type Journal Article
    ZDB-ID 2494856-1
    ISSN 1178-6973
    ISSN 1178-6973
    DOI 10.2147/IDR.S376401
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top